International Journal of Clinical Practice / 2022 / Article / Tab 1 / Research Article
Genetic Diversity, Carbapenem Resistance Genes, and Biofilm Formation in UPEC Isolated from Patients with Catheter-Associated Urinary Tract Infection in North of Iran Table 1 Carbapenemase production and its association with antibiotic resistance in UPEC.
Category Antibiotics Carbapenem-positive 48 no. (%) Carbapenem-negative 10 no. (%) Unknown-carbapenem 18 no. (%) Resistant Susceptible Resistant Susceptible Resistant Susceptible Carbapenem IPM 14 (29) 34 (71) 2 (20) 8 (80) 6 (33) 12 (67) 0.756 Cephalosporin CTX 34 (71) 14 (29) 2 (20) 8 (80) 15 (84) 3 (16) 0.002 CRO 32 (66) 16 (44) 2 (20) 8 (80) 16 (89) 2 (11) 0.001 Aminoglycosides AN 9 (19) 39 (81) 0 10 (100) 3 (16) 15 (84) 0.394 GM 15 (31) 33 (69) 0 10 (100) 7 (38) 11 (62) 0.080 Sulfonamides SXT 39 (81) 9 (19) 6 (60) 4 (40) 16 (89) 2 (11) 0.177 Quinolones CP 32 (66) 16 (44) 2 (20) 8 (80) 14 (77) 4 (23) 0.007 NA 41 (85) 7 (15) 6 (60) 4 (40) 15 (84) 3 (16) 0.165 Nitrofurans FM 9 (19) 39 (81) 2 (20) 8 (80) 3 (16) 15 (84) 0.972 Genes Genes Positive Negative Positive Negative Positive Negative bla NDM 8 (16) 40 (84) 1 (10) 9 (90) 2 (11) 16 (89) 0.774 bla KPC 0 48 (100) 0 10 (100) 0 18 (100) 0 bla oxa-48 2 (4) 46 (96) 0 10 (100) 0 18 (100) 0.549 bla oxa-23 1 (2) 47 (98) 0 10 (100) 1 (5.5) 17 (94.5) 0.629 bla IPM 1 (2) 47 (98) 0 10 (100) 0 18 (100) 0.744 bla VIM 1 (2) 47 (98) 0 10 (100) 0 18 (100) 0744
AN: Amikacin; IPM: Imipenem; FM: Nitrofurantoin; SXT: Trimethoprim-Sulfamethoxazole; CTX: Cefotaxime; GM: Gentamicin; CRO: Ceftriaxone; CP: Ciprofloxacin; and NA: Nalidixic acid.
